Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
In-licensing

Oral, Topical or Transdermal products in any therapeutical area

APR Applied Pharma Research S.A.
APR is interested to in-license new early stage, innovative and patent protected products/technologies (preferably off patent or close to expiry) for oral, topical or transdermal administration

Full description

APR is interested to evaluate in-licensing opportunities which fit with APR's strategy:

  1. Innovative product opportunities preferably where the innovation is given by the drug delivery system used;
  2. They are for Oral, Topical or Transdermal administration
  3. Patent Protected at least in EU and US

Development status

Phase II

Type of business relationship sought

We do not seek a specific type of business relationship: the structure of any business relationship we have entered was driven by the ultimate objective to always create a win-win relation.

Over time, APR has experienced several business relationships ranging from pure In-licensing deals to Joint Venture, Partnership or Co-development agreements.

Partnering consultation free of charge
BioNetwork West 2008
Yissum Technology Transfer Hebrew University
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us